Evidence map›Paper›PMID 40857416›Full record

ArticleAnnals of the Child Neurology Society2025

Clinically Important Endpoints in Individuals With Leukodystrophy: A Multisite Study.

Emma R Kotes, Sarah Woidill, Russell D'Aiello, Amina Khan, Jacob McCann, Mark Ramos, Francesco Gavazzi, Stephanie Keller, Keith Van Haren, Ali Fatemi and 22 more

Abstract read
In one paragraph

Article in Annals of the Child Neurology Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors.

Emma R KotesDivision of Neurology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Sarah WoidillDivision of Neurology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Russell D'AielloDepartment of Biomedical and Health Informatics, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Amina KhanDepartment of Biomedical and Health Informatics, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Jacob McCannSchool of Medicine, Case Western Reserve University, Cleveland, OH, USA.
Mark RamosDepartment of Biomedical and Health Informatics, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Francesco GavazziDivision of Neurology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Stephanie KellerDepartment of Pediatrics, Division of Pediatric Neurology, Emory University, Atlanta, GA, USA.
Keith Van HarenDepartment of Neurology, Stanford University, Palo Alto, CA, USA.
Ali FatemiMoser Center for Leukodystrophies, Kennedy Krieger Institute, Baltimore, MD, USA.
Florian EichlerDepartment of Neurology, Massachusetts General Hospital, Boston, MA, USA.
Joshua BonkowskyDivision of Pediatric Neurology, Department of Pediatrics, University of Utah, Salt Lake City, UT, USA.
Jamie FraserLeukodystrophy and Myelin Disorders Program, Children's National Medical Center, Washington, DC, USA.
Lisa EmrickNeurology and Developmental Neuroscience, Baylor College of Medicine, Houston, TX, USA; Department of Neurology and Genetics, Texas Children's Hospital, Houston, TX, USA.
Omar SherbiniDivision of Neurology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Ashley HackettDepartment of Pediatrics, Division of Pediatric Neurology, Emory University, Atlanta, GA, USA.
Jeilo GaunaDepartment of Neurology, Lucile Packard Children's Hospital, Palo Alto, CA, USA.
Dandre AmosNational Institutes of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA.
Jordan GoodmanMoser Center for Leukodystrophies, Kennedy Krieger Institute, Baltimore, MD, USA.
Amena Smith FineDepartment of Neurology, Johns Hopkins School of Medicine, Baltimore, MD, USA.
Amanda NagyDepartment of Neurology, Massachusetts General Hospital, Boston, MA, USA.
Seungil LeeDepartment of Neurology, Massachusetts General Hospital, Boston, MA, USA.
Nicole PageDepartment of Neurology, Massachusetts General Hospital, Boston, MA, USA.
Johanna SchmidtDivision of Neurology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Amy PizzinoDivision of Neurology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Kayla MuirheadAmbry Genetics, Aliso Viejo, CA, USA.
Mariko BennettDivision of Neurology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Amy WaldmanDivision of Neurology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Justine ShultsDepartment of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Laura AdangDivision of Neurology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Robert GrundmeierDepartment of Biomedical and Health Informatics, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Adeline VanderverDivision of Neurology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.

Funding

Validation of the GMFC-MLDU54NS115052 · NINDS · CHILDREN'S HOSP OF PHILADELPHIA · PI Laura Ann Adang, FLORIAN S EICHLER · 2019 to 2026
$14.3M
Sleep and Circadian Dysfunction, Brain and Neurobehavioral Development in AutismP50HD103538 · NICHD · HUGO W. MOSER RES INST KENNEDY KRIEGER · PI S. Ali Fatemi, Bradley L Schlaggar · 2020 to 2026
$9.9M
NICHD NIH HHS P50 HD103538NINDS NIH HHS U54 NS115052
6 · The paper itself

Abstract

Importance: Leukodystrophies are a diverse group of rare disorders that disrupt central myelination. These disorders present with a broad spectrum of neurologic severity and are associated with a range of potential secondary complications, such as scoliosis and failure of independent feeding. Objective: we explore real-world data of leukodystrophy complications to inform future evidence-based care guidelines across these rare diseases. Design: In a cross-sectional observational study, we use a leukodystrophy-specific research consortium and the availability of electronic health records (EHR) to capture a cross-section of real-world data. Setting: Subjects were identified using EHR data from five hospital systems with established expertise in leukodystrophies. Participants: Principal investigators or genetic counselors confirmed leukodystrophy diagnoses in all subjects. Exposures: Time-to-event measures were collected, including orthopedic complications (scoliosis, hip subluxation/dislocation), loss of ambulation, artificial ventilation, gastrostomy tube placement, and urinary tract infections (UTIs). Maximum motor milestones, including gain of ambulation by 2 years old, were captured to stratify cohorts by neurologic severity. Main Outcome and Measure: A primary outcome was not prespecified as this was an observational study. Results: In total, 1203 subjects were identified across 42 leukodystrophies (age range of nine days to 89 years at last encounter). The most common event was feeding tube placement, and the median time to any first complication varied between disorders (Fleming-Harrington weighted log-rank test). The specific diagnosis correlated with maximum gross motor milestone attainment (Chi-square test of independence). When all disorders were stratified by maximum motor milestone attainment (not specific diagnosis), the median time to adverse events was significantly associated with function (Fleming-Harrington weighted log-rank test). Conclusions: This cross-sectional, retrospective observational study demonstrated that key medical events could be identified across institutions using EHR capture. Rates of health events and attainment of maximum motor milestones varied by specific leukodystrophy type. However, when the overall cohort was stratified by severity of motor impairment rather than individual diagnoses, the frequency of health events was associated with motor function. Our findings suggest utility for development of comprehensive care models for leukodystrophies as stratified by motor function, and demonstrate the utility of integrated EHR review for real-world data analyses.

Identifiers

PMID40857416
PMCPMC12369899

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.